Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
222.1 USD | +0.12% | -1.10% | +8.15% |
May. 17 | JPMorgan Adjusts Price Target on Cencora to $280 From $270 | MT |
May. 08 | Jefferies Adjusts Price Target on Cencora to $230 From $235 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company shows low valuation levels, with an enterprise value at 0.16 times its sales.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.15% | 44.3B | B- | ||
-5.43% | 181B | C+ | ||
+4.30% | 114B | C | ||
-3.09% | 68.29B | A | ||
+5.86% | 52.24B | B- | ||
+7.52% | 42.73B | B+ | ||
+25.54% | 32.52B | B | ||
+17.85% | 26.02B | A- | ||
+1.00% | 25.91B | A- | ||
-1.25% | 24.72B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- COR Stock
- Ratings Cencora, Inc.